Michele Malagola

Michele Malagola

UNVERIFIED PROFILE

Are you Michele Malagola?   Register this Author

Register author
Michele Malagola

Michele Malagola

Publications by authors named "Michele Malagola"

Are you Michele Malagola?   Register this Author

64Publications

1318Reads

39Profile Views

Zebrafish disease models in hematology: Highlights on biological and translational impact.

Biochim Biophys Acta Mol Basis Dis 2019 Mar 26;1865(3):620-633. Epub 2018 Dec 26.

Unit of Blood Disease and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST-Spedali Civili di Brescia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2018.12.015DOI Listing
March 2019

Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing.

Bone Marrow Transplant 2019 01 16;54(1):159-163. Epub 2018 Aug 16.

Research, Innovation and Statistics Department. A, Lacassagne Cancer Center, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0268-4DOI Listing
January 2019

The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era.

Blood Res 2018 Mar 27;53(1):3-6. Epub 2018 Mar 27.

Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST Spedali Civili, Brescia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2018.53.1.3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898991PMC
March 2018

Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence?

Infect Control Hosp Epidemiol 2017 09 31;38(9):1131-1132. Epub 2017 Jul 31.

1Clinical and Experimental Sciences Department,University of Brescia,Bone Marrow Transplant Unit,ASST-Spedali Civili,Brescia,Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/ice.2017.157DOI Listing
September 2017

Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.

Transplantation 2016 Dec;100(12):e147-e155

1 Hematology, Bone Marrow Transplantation Unit, Department of Clinical and Experimental Sciences, University of Brescia, Italy. 2 Immunohematology and Transfusion Medicine Unit, AO Spedali Cvili, Brescia, Italy. 3 SODc Terapia Cellulare e Medicina Trasfusionale, AOU Careggi, Firenze, Italy. 4 Divisione di Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy. 5 SC Ematologia, Istituto Nazionale Tumori, Milano, Italy. 6 Clinica Ematologica e Unità di terapie Cellulari, DISM, Università di Udine, Italy. 7 Centro di Ricerca Emato-oncologica AIL (CREA) Brescia, AO Spedali Civili di Brescia, Italy. 8 Unità di Cellule Staminali, Istituto Europeo di Oncologia, Milano, Italy. 9 Medicina Trasfusionale, Azienda Ospedaliero-Universitaria di Udine, Italy. 10 UO di Emotrasfusione, Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy. 11 Bone Marrow Transplant Unit SODc Ematologia, AOU Careggi, Firenze, Italy.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/TP.0000000000001466DOI Listing
December 2016

Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives.

Ann Hematol 2016 Apr 19;95(5):681-93. Epub 2016 Feb 19.

Department of Hematology/Oncology "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2617-yDOI Listing
April 2016

An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes.

J Leukoc Biol 2015 Nov 14;98(5):769-80. Epub 2015 May 14.

*Cellular Signalling Laboratory, Institute of Human Anatomy, Dipartimento di Scienze Biomediche e NeuroMotorie, University of Bologna, Italy; Institute of Hematology "L. e A. Seràgnoli," S. Orsola-Malpighi University Hospital, Bologna, Italy; Hematology and Stem Cell Transplant Center, San Salvatore Hospital, Pesaro, Italy; Unit of Blood Disease and Stem Cell Transplantation, University of Brescia, Italy; and Hematology Unit, Ospedale Civile di Piacenza, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.2MA1114-541RDOI Listing
November 2015

Peripheral blood WT1 expression predicts relapse in AML patients undergoing allogeneic stem cell transplantation.

Biomed Res Int 2014 17;2014:123079. Epub 2014 Aug 17.

Unit of Blood Disease and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, AO Spedali Civili di Brescia, P.le Ospedali Civili 1, 25123 Brescia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/123079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150519PMC
June 2015

Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers.

Oncologist 2015 Mar 10;20(3):323-8. Epub 2015 Feb 10.

Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Hematology and BMT Unit, University of Brescia, Brescia, Italy; Hematology, Azienda Ospedaliera-Universitaria, Udine, Italy; Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350807PMC
March 2015

Changes in circulating endothelial cells count could become a valuable tool in the diagnostic definition of acute graft-versus-host disease.

Transplantation 2014 Oct;98(7):706-12

1 Laboratory for Stem Cells Manipulation and Cryopreservation, A.O. Spedali Civili, Brescia, Italy. 2 Department of Transfusion Medicine, A.O. Spedali Civili, Brescia, Italy. 3 Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, A.O. Spedali Civili, Brescia, Italy. 4 Address correspondence to: Camillo Almici, M.D., Laboratory for Stem Cells Manipulation and Cryopreservation, Department of Transfusion Medicine, A.O. Spedali Civili di Brescia, Pz.le Spedali Civili, 1-25123 Brescia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000385DOI Listing
October 2014

Conditioning regimens in acute myeloid leukemia.

Expert Rev Hematol 2014 Aug;7(4):465-79

Hematology and Transplant Center, AORMN, Pesaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2014.939066DOI Listing
August 2014

Central nervous system angiitis in Hodgkin's disease.

J Neurol 2013 Nov 18;260(11):2897-9. Epub 2013 Oct 18.

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Piazzale Spedali Civili 1, 25125, Brescia, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-013-7122-9DOI Listing
November 2013

Treatment of chronic myeloid leukemia elderly patients in the tyrosine kinase inhibitor era.

Curr Cancer Drug Targets 2013 Sep;13(7):755-67

Chair of Hematology, Unit of Blood Diseases and Cell Therapies, University of Brescia - AO Spedali Civili Brescia, P.le Spedali Civili 1, 25100 Brescia, Italy.

View Article

Download full-text PDF

Source
September 2013

Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease.

Expert Rev Hematol 2013 Aug;6(4):475-83

Dipartimento di Medicina Interna--Az. Spedali Civili di Brescia e Università di Brescia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/17474086.2013.81
Publisher Site
http://dx.doi.org/10.1586/17474086.2013.814835DOI Listing
August 2013

Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.

Leuk Res 2010 Jul 31;34(7):942-5. Epub 2010 Jan 31.

Clinica Ematologica e Centro Trapianti e Terapie Cellulari C. Melzi, Azienda Ospedaliero-Universitaria di Udine, Dipartimento di Ricerche Mediche e Morfologiche, Università di Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521261000009
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2010.01.008DOI Listing
July 2010

Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.

Leuk Res 2008 Dec 14;32(12):1800-8. Epub 2008 Jul 14.

Division of Hematology, Bone Marrow Transplantation Unit, Department of Clinical and Morphological Research, University Hospital, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.05.011DOI Listing
December 2008

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias.

Biologics 2008 Sep;2(3):419-31

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721375PMC
September 2008

Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation.

Leuk Lymphoma 2006 Mar;47(3):469-72

Institute of Haematology and Medical Oncology 'L. and A. Serànoli', S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190500331261DOI Listing
March 2006

First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients.

Leuk Res 2004 Sep;28(9):987-90

Institute of Haematology and Medical Oncology, L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2004.01.009DOI Listing
September 2004

Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?

Leuk Lymphoma 2004 Aug;45(8):1531-8

Department of Hematology, H. San Salvatore, Pesaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190310001653727DOI Listing
August 2004

Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation.

Leuk Lymphoma 2004 Apr;45(4):731-3

Institute of Haematology and Medical Oncology, "L and A Seràgnoli", S. Orsola-Malpighi Hospital, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190310001603948DOI Listing
April 2004

Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.

Haematologica 2004 Feb;89(2):236-7

Institute of Hematology and Medical Oncology "L and A Seràgnoli", University of Bologna, Italy.

View Article

Download full-text PDF

Source
February 2004

Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly.

Haematologica 2003 Dec;88(12):ECR37

Institute of Haematology and Medical Oncology L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Italy.

View Article

Download full-text PDF

Source
December 2003

Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC.

Clin Chem 2003 Oct;49(10):1642-50

Institute of Hematology and Medical Oncology L. e A. Seràgnoli, University of Bologna, Via Massarenti No. 9, 40138 Bologna, Italy.

View Article

Download full-text PDF

Source
October 2003